WallStreetZenWallStreetZen

NASDAQ: BNGO
Bionano Genomics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bionano Genomics earnings were -$32.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BNGO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$7.4M, down 10.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BNGO reported annual earnings of -$26.4M, with -76.4% growth.

BNGO earnings history

Current Revenue
$30.2M
Current Earnings
-$32.2M
Current Profit Margin
-106.6%

BNGO Return on Equity

Current Company
-78.8%
Current Industry
8.8%
Current Market
31%
BNGO's Return on Equity (-78.8%)... subscribe to Premium to read more.
High Return on Equity Performance

BNGO Return on Assets

Current Company
-48.5%
Current Industry
7.3%
BNGO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BNGO announces earnings.

BNGO Return on Capital Employed

Current Company
-85.47%
Current Industry
11%
BNGO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNGO vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BNGO-$22.15M-$32.16MN/A-$3.02
ZJYL$1.58M$1.17M-81.81%$0.19
RVP$4.53M-$3.60MN/A-$0.12
RGNT-$13.02M-$13.02MN/A-$23.43
FEMY-$10.16M-$12.29MN/A-$3.53
View Top Medical Stocks

Bionano Genomics Earnings Reports & History FAQ

What were Bionano Genomics's earnings last quarter?

On BNGO's earnings call on Aug 10, 2026, Bionano Genomics (NASDAQ: BNGO) reported Q2 2026 earnings per share (EPS) of -$0.64, up 67.84% year over year. Total BNGO earnings for the quarter were -$7.42 million. In the same quarter last year, Bionano Genomics's earnings per share (EPS) was -$1.99.

If you're new to stock investing, here's how to buy Bionano Genomics stock.

Is Bionano Genomics profitable or losing money?

As of the last Bionano Genomics earnings report, Bionano Genomics is currently losing money. Bionano Genomics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$32.16 million, a 56.73% decrease year over year.

What was BNGO's earnings growth in the past year?

As of Bionano Genomics's earnings date in Aug 10, 2026, Bionano Genomics's earnings has grown year over year. BNGO earnings in the past year totalled -$32.16 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.